CAROLINE MCDONALD: Open Payments
NPI 1922342500 · SOUTH BEND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$602 in 30 payments from 10 companies in 2025. Trend: 2023 $805 · 2024 $1,061 · 2025 $602
Food & beverage: $602
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $183 |
| Regeneron Healthcare Solutions, Inc. | 4 | $124 |
| GENZYME CORPORATION | 4 | $77 |
| Lilly USA, LLC | 3 | $55 |
| Amgen Inc. | 2 | $38 |
| Galderma Laboratories, L.P. | 1 | $36 |
| Incyte Corporation | 1 | $30 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| ABBVIE INC. | 1 | $22 |
| Janssen Biotech, Inc. | 1 | $14 |
Products named: DUPIXENT, COSENTYX, OTEZLA, NEMLUVIO, EBGLYSS, OPZELURA, ZERBAXA, TALTZ.
Industry payments across IN — which companies pay providers there.
